Surgery for Pancreatic Cancer

Mar 1, 2017 by in HEMATOLOGY Comments Off on Surgery for Pancreatic Cancer

Surgical resection remains the only potentially curative therapy for pancreatic cancer, despite a high rate of systemic recurrence. Because of local invasion or distant spread, a minority of patients presenting…

read more

Diagnosis and Management of Pancreatic Cystic Neoplasms

Mar 1, 2017 by in HEMATOLOGY Comments Off on Diagnosis and Management of Pancreatic Cystic Neoplasms

Incidentally discovered pancreatic cystic lesions are increasingly common, affecting up to 10% to 15% of patients undergoing cross-sectional imaging. Although some pancreatic cystic neoplasms harbor invasive malignancy or the potential…

read more

Familial Pancreatic Adenocarcinoma

Mar 1, 2017 by in HEMATOLOGY Comments Off on Familial Pancreatic Adenocarcinoma

Familial pancreatic cancer (FPC) kindreds have at least 2 first-degree relatives with pancreatic ductal adenocarcinoma. Studies of FPC have focused on the discovery of genetic cause and on the management…

read more

Pancreatic Cancer

Mar 1, 2017 by in HEMATOLOGY Comments Off on Pancreatic Cancer

Brian M. Wolpin, MD, MPH, Editor Although pancreatic cancer remains a leading cause of cancer death, steady progress is being made in understanding the biology of the disease and optimal…

read more

The Role of Hematopoietic Stem Cell Transplantation in Treatment of Hemophagocytic Lymphohistiocytosis

Mar 1, 2017 by in HEMATOLOGY Comments Off on The Role of Hematopoietic Stem Cell Transplantation in Treatment of Hemophagocytic Lymphohistiocytosis

The role of reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT) from a variety of donor sources in improving survival for children with familial hemophagocytic lymphohistiocytosis (HLH) is well-documented. The heterogeneity…

read more

Macrophage Activation Syndrome

Mar 1, 2017 by in HEMATOLOGY Comments Off on Macrophage Activation Syndrome

Macrophage activation syndrome (MAS) is a potentially life-threatening complication of rheumatic disorders that occurs most commonly in systemic juvenile idiopathic arthritis. In recent years, there have been several advances in…

read more
Get Clinical Tree app for offline access